REDUCED PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR THE PRODRUG CANDESARTAN CILEXETIL AND ITS ACTIVE METABOLITE CANDESARTAN ACID

被引：0
|
作者：
Nishimuta, Haruka [1 ]
Tsamandouras, Nikolaos [2 ]
Aarons, Leon [2 ]
Galetin, Aleksandra [2 ]
机构：
[1] Dainippon Sumitomo Pharma Co Ltd, Preclin Res Labs, Osaka, Japan
[2] Univ Manchester, Manchester Pharm Sch, Ctr Appl Pharmacokinet Res, Manchester, Lancs, England
来源：
DRUG METABOLISM REVIEWS | 2015年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P363
引用
下载
收藏
页码：210 / 210
页数：1
相关论文
共 50 条
  • [1] A PHYSIOLOGICALLY-BASED POPULATION PHARMACOKINETIC MODEL FOR SIMVASTATIN AND ITS ACTIVE METABOLITE SIMVASTATIN ACID
    Tsamandouras, Nikolaos
    Dickinson, Gemma
    Hall, Stephen
    Rostami-Hodjegan, Amin
    Galetin, Aleksandra
    Aarons, Leon
    DRUG METABOLISM REVIEWS, 2014, 45 : 230 - 231
  • [2] REDUCED PARENT-METABOLITE(S) PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL: APPLICATION TO MYCOPHENOLIC ACID
    Matsunaga, Norikazu
    Darwich, Adam
    Ogungbenro, Kayode
    Galetin, Aleksandra
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S69 - S69
  • [3] A physiologically-based pharmacokinetic model of oseltamivir phosphate and its carboxylate metabolite for rats and humans
    Gao, Guanghua
    Law, Francis
    Wong, Ricky Ngok Shun
    Mak, Nai Ki
    Yang, Mildred Sze Ming
    ADMET AND DMPK, 2019, 7 (01): : 22 - 43
  • [4] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR ACETONE
    KUMAGAI, S
    MATSUNAGA, I
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1995, 52 (05) : 344 - 352
  • [5] Host-Guest Interactions between Candesartan and Its Prodrug Candesartan Cilexetil in Complex with 2-Hydroxypropyl-β-cyclodextrin: On the Biological Potency for Angiotensin II Antagonism
    Ntountaniotis, Dimitrios
    Andreadelis, Ioannis
    Kellici, Tahsin F.
    Karageorgos, Vlasios
    Leonis, Georgios
    Christodoulou, Eirini
    Kiriakidi, Sofia
    Becker-Baldus, Johanna
    Stylos, Evgenios K.
    Chatziathanasiadou, Maria V.
    Chatzigiannis, Christos M.
    Damalas, Dimitrios E.
    Aksoydan, Busecan
    Javornik, Uros
    Valsami, Georgia
    Glaubitz, Clemens
    Durdagi, Serdar
    Thomaidis, Nikolaos S.
    Kolocouris, Antonios
    Plavec, Janet
    Tzakos, Andreas G.
    Liapakis, George
    Mavromoustakos, Thomas
    MOLECULAR PHARMACEUTICS, 2019, 16 (03) : 1255 - 1271
  • [6] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR THE ANTIBIOTIC ERTAPENEM
    Joyner, Michele L.
    Manning, Cammey C.
    Forbes, Whitney
    Maiden, Michelle
    Nikas, Ariel N.
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2016, 13 (01) : 119 - 133
  • [7] A physiologically-based pharmacokinetic (PBPK) model of hydroxychloroquine
    Collins, Keagan P.
    Jackson, Kristen M.
    Gustafson, Daniel L.
    CANCER RESEARCH, 2017, 77
  • [8] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF ETHANOL IN THE MOUSE
    PASTINO, GM
    SULTATOS, LG
    FLYNN, EJ
    FASEB JOURNAL, 1994, 8 (05): : A952 - A952
  • [9] Physiologically-Based Pharmacokinetic Modelling of Entrectinib Parent and Active Metabolite to Support Regulatory Decision-Making
    Djebli, Nassim
    Buchheit, Vincent
    Parrott, Neil
    Guerini, Elena
    Cleary, Yumi
    Fowler, Stephen
    Frey, Nicolas
    Yu, Li
    Mercier, Francois
    Phipps, Alex
    Meneses-Lorente, Georgina
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2021, 46 (06) : 779 - 791
  • [10] Physiologically-Based Pharmacokinetic Modelling of Entrectinib Parent and Active Metabolite to Support Regulatory Decision-Making
    Nassim Djebli
    Vincent Buchheit
    Neil Parrott
    Elena Guerini
    Yumi Cleary
    Stephen Fowler
    Nicolas Frey
    Li Yu
    François Mercier
    Alex Phipps
    Georgina Meneses-Lorente
    European Journal of Drug Metabolism and Pharmacokinetics, 2021, 46 : 779 - 791
12345